Skip to content
healthcare.dev

Temozolomide

NDC 73043-012, Temozolomide, capsule, from Devatis, Inc..

Product NDC
73043-012
Status
Listed
Labeler
Devatis, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207658
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73043-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TEMOZOLOMIDE20 mg/1

Pharmacologic classes

Alkylating Activity [MoA]; Alkylating Drug [EPC]

Package NDCNDC-11Package
73043-012-05730430012055 CAPSULE in 1 BOTTLE (73043-012-05)
73043-012-147304300121414 CAPSULE in 1 BOTTLE (73043-012-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6b263fe0-5f06-4889-bf14-4aa185470810
  • NADAC price for package 73043001205

    GET /v1/drugs/nadac/73043001205
  • NADAC price for package 73043001214

    GET /v1/drugs/nadac/73043001214

Use it

Look up 73043-012 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73043-012 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73043-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.